Searching for a cure, Improving lives

DMD Carrier Leaflet


Action Duchenne, in collaboration with Sue Kenwrick, Principal Genetic Councellor, Addenbrooke’s Hospital, Cambridge, have produced a ground-breaking leaflet ‘Being a Carrier for Duchenne Muscular Dystrophy’.

This leaflet was distributed to all Neuromuscular Centres, Genetic Services and groups working with families affected by Duchenne muscular dystrophy.

The inspiration for this leaflet came from workshops for Duchenne carriers and other female relatives held by Action Duchenne, as well as sibling events and discussions arising from the ‘What about Us’ element of the Lottery funded Takin’ Charge. Takin’ Charge looks at issues in Transition for young people and their families, affected by Duchenne.

The format of the leaflet follows frequently asked questions that come up when carriers or relatives are given an opportunity to discuss the issues involved.

The project has been led by the Duchenne community, thank you to all contributors who have made this valuable resource possible.

Please click here to take a look at the leaflet online (please note the following amendments to the links below)

  • Muscular Dystrophy UK
  • Genetic Alliance UK

If you have further questions or comments please contact us

We received some patient info leaflets on being a Duchenne carrier last week – just wanted to let you know that the Genetic Counsellors in the department were very pleased with them and will make good use of them” – Nicole Gossan PhD, Pre-Registration Clinical Scientist (Genomics), Molecular Genetics Laboratory, Cheshire and Merseyside Regional Genetics, Liverpool Women’s Hospital


Support Action Duchenne with a monthly or one off donation



View our events

View All Events


Join the DMD registry for access to clinical trials


Action Duchenne launches new Research Strategy for Duchenne muscular dystrophy

November 17th, 2017

  Action Duchenne, a leading UK-wide patient and parent-led organisation for Duchenne Muscular Dystrophy, is

Tell me more

Long-term microdystrophin pre-clinical work, moving towards a potential therapy restores muscle function in canines

July 26th, 2017

Promising microdystrophin pre-clinical work, moving towards a potential therapy has shown to restore muscle function

Tell me more

FDA new approach would reduce number of patients treated with placebo

December 11th, 2017

The U.S. Food and Drug Administration (FDA) has published its recommendation for a new approach

Tell me more

Results announced from survey ‘Juggling care and daily life’

December 11th, 2017

The 17th October 2017 was an important date for the rare disease community.  The highlights of the

Tell me more

Duchenne – How do you measure a life?

Living with Duchenne – an animation

Taking charge of Duchenne

wordpress counter

Stay informed with regular updates from Action Duchenne